An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England is a paper indexed in ScholarIQ from OpenAlex.
How many citations does An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England have?
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England has 81 citations in the OpenAlex counts ScholarIQ stores.
When was An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England published?
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England has 2013 year in the ScholarIQ index.
What is the open-access status of An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England?
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England has hybrid oa status in the ScholarIQ index.
What is the DOI of An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England?
The DOI for An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England is on the source record.
What is the PMID of An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England?
The PMID for An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England is on the source record.
What is the OpenAlex record for An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England?
The OpenAlex for An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for <i>Chlamydia trachomatis</i> and <i>Neisseria gonorrhoea</i> in genitourinary medicine clinics in England is on the source record.